CardiacSense
Provider of sensor to monitor heart arrhythmia and vital signs. It develops medical sensors that can continuously monitor and diagnose patients non-invasively, over the wrist. It can be used to monitor cardiac arrest, atrial fibrillation, and vital signs. Founded in 2012, headquartered in Caesarea, Israel. The company has raised $14.5M in funding at the series b stage. The team comprises 10+ (Mar 1, 2026) employees.…
Funding snapshot
About
Provider of sensor to monitor heart arrhythmia and vital signs. It develops medical sensors that can continuously monitor and diagnose patients non-invasively, over the wrist. It can be used to monitor cardiac arrest, atrial fibrillation, and vital signs. Founded in 2012, headquartered in Caesarea, Israel. The company has raised $14.5M in funding at the series b stage. The team comprises 10+ (Mar 1, 2026) employees. The company operates in the Cardiac and Vascular Disorders sector with additional focus on Disease Self Management and Healthcare IT. Its business model centers on Cardiac. Founded in 2012, headquartered in Caesarea, Israel. The company has raised $14.5M at the Series B stage. Backed by investors including EIC Fund, Europa, Merchavia Holdings and Investments, Cashline Investment Holding.
Business model
Wearable Technology > Health and Wellness Devices > Cardiac,
Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > Device > Wearable,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Cardiology > Wearable,
Cardiac and Vascular Disorders > Medical Devices > Screening Devices > Cardiac Diagnostic > Electrodiagnostic Testing (ECG) > Home Based
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.